Women’s
healthcare company TherapeuticsMD announced it has received a notice of
allowance from the U.S. Patent and Trademark Office regarding its U.S. patent
application 13/684,002, “Natural Combination Hormone Replacement Formulations
and Therapies.” The patent application covers TherapeuticsMD’s technology TX
12-001-HR, an oral bioidentical 17-estradiol and progesterone combination drug
candidate.
The
receipt of this patent allowance is a key step for TherapeuticsMD toward
solidifying its IP protection for this important technology, particularly in
relation to lead product candidate TX 12-001-HR. Previously, it has been
extremely difficult to combine the bioidentical hormones 17-estradiol and
progesterone and achieve consistent bioavailability. Based on clinical data
that was presented earlier this year, TherapeuticsMD believes TX 12-001-HR has
overcome past obstacles and that this novel combination of 17-estradiol and
progesterone may successfully achieve equivalent efficiency with improved
bioavailability, as compared with current hormone therapies. The company
eagerly awaits the outcome of its ongoing REPLENISH Trial.
A
women’s healthcare company, TherapeuticsMD is focused on the development and
commercialization of products targeted exclusively at women. The company is in
the process of developing advanced hormone therapy pharmaceutical products
based on novel technologies that enable delivery of bioidentical hormones
through various dosage forms and administration routes. TherapeuticsMD also
manufactures and distributes branded and generic prescription prenatal vitamins
and over-the-counter vitamins and cosmetics under its vitaMedMD and BocaGreenMD
brands.
For
more information, visit www.therapeuticsmd.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
